CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Alexion Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 31, 2018
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 21, 2018
Antibodies With Modified Affinity To Fcrn That Promote Antigen ClearanceCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 2, 2018

Explore Alexion Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
May 1, 2024Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement3
Jan 4, 2023Methods And Compositions For Treating Complement-Associated Disorders2
Nov 27, 2019Compositions And Methods For Increasing The Serum Half-Life Of A Therapeutic Agent Targeting Complement C52
Jul 31, 2019Methods Of Shifting An Isoelectric Profile Of A Protein Product And Uses Thereof1

Top competitors of Alexion Pharmaceuticals

List of top competitors of Alexion Pharmaceuticals based on patent oppositions.